Generalized lichen planus pigmentosus and a new management approach
- PMID: 38799517
- PMCID: PMC11111602
- DOI: 10.1002/ccr3.8829
Generalized lichen planus pigmentosus and a new management approach
Abstract
Generalized lichen planus pigmentosus significantly improved with the daily administration of Tofacitinib at a dosage of 15 mg.
Keywords: generalized lichen planus pigmentosus; janus kinase inhibitors; lichen planus; tofacitinib.
© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
None.
Figures



References
-
- Robles‐Méndez JC, Rizo‐Frías P, Herz‐Ruelas ME, Pandya AG, Ocampo CJ. Lichen planus pigmentosus and its variants: review and update. Int J Dermatol. 2018;57(5):505‐514. - PubMed
-
- Al‐Rqobah D. Lichen planus pigmentosus: an overview. Gulf J Dermatol Venereol, 2019;26(1):3‐7.
-
- Li R, Zhang J, Jiang Y, KCA in D . A case of generalized lichen planus pigmentosus: an atypical clinical variety. termedia. Postȩpy Dermatologii i Alergologii. 2022;3(3):627. https://www.termedia.pl/A‐case‐of‐generalized‐lichen‐planus‐pigmentosus‐... - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources